ALAS-E Antibodies

Santa Cruz Biotechnology delivers a wide array of ALAS-E monoclonal antibodies for research focused on understanding aminolevulinate synthase. ALAS-E monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ALAS-E, or aminolevulinate synthase, is a key enzyme in the heme biosynthesis pathway, catalyzing the first step in the production of porphyrins. Aminolevulinate synthase plays a crucial role in the synthesis of heme, which is essential for various biological processes, including oxygen transport and electron transfer in cellular respiration. Understanding the function and regulation of aminolevulinate synthase provides insights into disorders related to heme metabolism. Research involving ALAS-E has significant implications for developing therapeutic strategies targeting heme-related disorders. Investigating aminolevulinate synthase helps advance knowledge in cellular metabolism and disease mechanisms. ALAS-E monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to make meaningful contributions to heme biosynthesis research and therapeutic development.